Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC-Reference-Cited by-同舟云学术

Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC

Published:2019-11 Issue:11 Volume:27 Page:1906-1918
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zhang Yonghui,Zhang Hailin,Wei Mei,Mou Tao,Shi Tao,Ma Yanyu,Cai Xinyu,Li Yunzheng,Dong Jie,Wei Jiwu

Funder

National Natural Science Foundation of China

Six talent peaks project in Jiangsu Province

Natural Science Foundation of Jiangsu Province of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Cancer immunoediting and resistance to T cell-based immunotherapy;O’Donnell;Nat. Rev. Clin. Oncol.,2019

2. Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference;Dyer;Cancer Gene Ther.,2019

3. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells;Bischoff;Science,1996

4. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial;Nemunaitis;Cancer Res.,2000

5. Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy;Ribas;Cell,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications;Biomarker Research;2024-09-02

2. Oncolytic virotherapy for hepatocellular carcinoma: A potent immunotherapeutic landscape;World Journal of Gastrointestinal Oncology;2024-07-15

3. Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice;Journal of Experimental & Clinical Cancer Research;2024-04-03

4. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

5. Immunotherapy for hepatocellular carcinoma: molecular pathogenesis and clinical research progress;Oncology and Translational Medicine;2023-12-22